Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

788 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung Cancer: Are we up to the Challenge?
Esposito L, Conti D, Ailavajhala R, Khalil N, Giordano A. Esposito L, et al. Curr Genomics. 2010 Nov;11(7):513-8. doi: 10.2174/138920210793175903. Curr Genomics. 2010. PMID: 21532835 Free PMC article.
ATP-noncompetitive CDK inhibitors for cancer therapy: an overview.
Abate AA, Pentimalli F, Esposito L, Giordano A. Abate AA, et al. Among authors: esposito l. Expert Opin Investig Drugs. 2013 Jul;22(7):895-906. doi: 10.1517/13543784.2013.798641. Epub 2013 Jun 4. Expert Opin Investig Drugs. 2013. PMID: 23735075 Review.
Could Puralpha be a cancer target?
Esposito L, Giordano A. Esposito L, et al. Cancer Biol Ther. 2008 Dec;7(12):1936-7. doi: 10.4161/cbt.7.12.7167. Epub 2008 Dec 9. Cancer Biol Ther. 2008. PMID: 18981716 No abstract available.
Treatment for glioma recurrence: new hope?
Esposito L, Caligiuri I, Giordano A. Esposito L, et al. Cancer Biol Ther. 2010 Jan;9(1):40-1. doi: 10.4161/cbt.9.1.10806. Epub 2010 Jan 1. Cancer Biol Ther. 2010. PMID: 20023371 No abstract available.
p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.
Vici P, Sperati F, Maugeri-Saccà M, Melucci E, Di Benedetto A, Di Lauro L, Pizzuti L, Sergi D, Terrenato I, Esposito L, Iannuzzi CA, Pasquale R, Botti C, Fuhrman B, Giordano A, Mottolese M, Barba M. Vici P, et al. Among authors: esposito l. Oncotarget. 2014 Nov 15;5(21):10382-92. doi: 10.18632/oncotarget.2060. Oncotarget. 2014. PMID: 25071015 Free PMC article.
788 results